Close
Help




JOURNAL

Lymphoma and Chronic Lymphocytic Leukemias

Mantle Cell Lymphoma: Individualizing Therapy

Submit a Paper


Lymphoma and Chronic Lymphocytic Leukemias 2015:5 1-9

Review

Published on 27 Jan 2015

DOI: 10.4137/LCLL.S13724


Further metadata provided in PDF



Sign up for email alerts to receive notifications of new articles published in Lymphoma and Chronic Lymphocytic Leukemias

Abstract

Despite substantial improvements in the management and treatment of mantle cell lymphoma (MCL), the disease is still considered incurable. While high-dose cytarabine followed by autologous stem cell transplantation (ASCT) is considered as the gold standard in younger patients, the Rituximab, Cyclophosphomide, Doxorubicin, Oncovin, Prednisone (R-CHOP) regimen followed by rituximab maintenance is the recommended treatment for the elderly. Our better understanding of the pathogenesis of the disease through the identification of different altered signaling pathways has contributed to the development of new-targeted therapies offering a new era in the management of MCL. Early results achieved with these therapies are promising. However, new questions are arising regarding how and when to use these agents. This paper reviews these different approaches in patients with MCL.



Downloads

PDF  (938.87 KB PDF FORMAT)

RIS citation   (ENDNOTE, REFERENCE MANAGER, PROCITE, REFWORKS)

BibTex citation   (BIBDESK, LATEX)


Sharing


What Your Colleagues Say About Libertas Academica
My experience with Clinical Medicine Insights: Case Reports was excellent.  The entire review process was fast and accurate.  My previous experience with important top ranking journals was unpleasant mainly because the staff were slow and sometimes presumptuous.  On the contrary, the editors of Libertas were helpful and prompt in responding to questions and issues related to the submission.  I recommend the publisher to my colleagues.
Dr Lucio Gnessi (Sapienza University of Rome, Italy)
More Testimonials

Quick Links


New article and journal news notification services
Email Alerts RSS Feeds
Facebook Google+ Twitter
Pinterest Tumblr YouTube